BackTable Brief: COSIRA II: Coronary Sinus Reducer: A Tool in Angina Care with Dr. Jai Khatri episode artwork

EPISODE · Apr 14, 2026 · 23 MIN

BackTable Brief: COSIRA II: Coronary Sinus Reducer: A Tool in Angina Care with Dr. Jai Khatri

from Backtable Cardiology · host BackTable Inc.

Summary This week, the coronary sinus isn’t the only thing getting reduced! Dr. Jai Khatri and Dr. Ziad Ali join this BackTable Brief to share strategies for reducing enrollment barriers for the COSIRA II coronary sinus reducer trial. They discuss refractory angina, emerging evidence for microvascular angina, and strategies to help patients achieve stable medical therapy and avoid resetting trial eligibility. TIMESTAMPS 00:00 - Introduction 01:46 - Maintaining Patients Eligibility 04:20 - Treadmill Test Reproducibility 07:16 - Patient Stories And Outcomes 11:39 - CTO vs. COSIRA-II Trial Candidacy 16:57 - Microvascular Angina: Evidence and Outlook CHECK OUT THE FULL EPISODE COSIRA II: Managing Refractory Angina in Clinical Practice https://www.backtable.com/shows/cardiology/podcasts/14/cosira-ii-refractory-angina-challenges-treatment-strategies RESOURCES COSIRA-II Trialhttps://clinicaltrials.gov/study/NCT05102019

Episode metadata supplied by the publisher feed · Published Apr 14, 2026

Embed this episode

NOW PLAYING

BackTable Brief: COSIRA II: Coronary Sinus Reducer: A Tool in Angina Care with Dr. Jai Khatri

0:00 23:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

ACC CardiaCast American College of Cardiology This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Julio G. Martinez-Clark Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.Why Listen?<ul JACC This Week American College of Cardiology A weekly co-hosted podcast featuring JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC and JACC Senior Consulting Editor Carolyn S.P. Lam, MBBS, PhD, giving readers context on our weekly issues. Listen in as they break down the latest trends and share practical tips that are changing the way heart care works globally. ESC Cardio Talk European Society of Cardiology The ESC podcasts - regular recordings from the European Society of Cardiology.Hear renowned experts discuss cardiovascular advances relevant to daily practice.Check here regularly to stay up to date.You can also be interested in other ESC podcasts: EHRA Cardio Talk, HFA Cardio Talk and ESC TV Today. Check them out!

Frequently Asked Questions

How long is this episode of Backtable Cardiology?

This episode is 23 minutes long.

When was this Backtable Cardiology episode published?

This episode was published on April 14, 2026.

Can I download this Backtable Cardiology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!